IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,018,000 | -20.6% | 949,000 | -20.3% | 0.00% | 0.0% |
| Q4 2020 | $1,282,000 | -29.9% | 1,190,000 | -32.7% | 0.00% | 0.0% |
| Q3 2020 | $1,830,000 | -1.1% | 1,769,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,851,000 | -0.6% | 1,769,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $1,862,000 | +399.2% | 1,769,000 | +405.4% | 0.00% | – |
| Q2 2019 | $373,000 | -83.3% | 350,000 | -82.8% | 0.00% | -100.0% |
| Q1 2019 | $2,232,000 | +145.0% | 2,030,000 | +108.2% | 0.00% | 0.0% |
| Q4 2018 | $911,000 | -64.0% | 975,000 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $2,531,000 | -2.1% | 1,950,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,585,000 | +1161.0% | 1,950,000 | +1014.3% | 0.00% | – |
| Q1 2018 | $205,000 | +144.0% | 175,000 | +136.5% | 0.00% | – |
| Q4 2016 | $84,000 | -4.5% | 74,000 | 0.0% | 0.00% | – |
| Q3 2016 | $88,000 | -94.3% | 74,000 | -95.1% | 0.00% | -100.0% |
| Q2 2016 | $1,547,000 | – | 1,511,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,000,000 | $1,164,000 | 0.58% |
| CSS LLC/IL | 7,044,000 | $8,236,000 | 0.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $39,039,000 | 0.45% |
| DeepCurrents Investment Group LLC | 5,056,000 | $5,872,000 | 0.26% |
| SSI INVESTMENT MANAGEMENT LLC | 3,175,000 | $3,696,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,850,000 | 0.17% |
| LINDEN ADVISORS LP | 10,269,000 | $12,015,000 | 0.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $2,126,000 | 0.11% |
| HBK INVESTMENTS L P | 10,116,000 | $11,822,000 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 16,000,000 | $18,783,000 | 0.03% |